PITTSBURGH–(BUSINESS WIRE)–This National Disability Employment Awareness Month, inventory intelligence solution Gather AI announces a new customer, Bosma Enterprises (Bosma), Indiana’s largest employer of people who are blind or visually impaired. Bo…
Author: Business Wire
Ora stärkt globales Führungsteam durch wichtige Ernennungen für Europa-Geschäft und Personalservice
BOSTON, Massachusetts, USA–(BUSINESS WIRE)–Ora, das weltweit führende Auftragsforschungsinstitut (CRO) für Augenheilkunde, hat Dr. Marcin Ernst, MBA, zum Vice President of Europe und Tim Neathery zum Chief People Officer ernannt. Mit diesen strategis…
Ora renforce son leadership mondial avec des nominations clés en Europe et dans les services aux personnes
BOSTON–(BUSINESS WIRE)–Ora, leader mondial de la recherche sous contrat en ophtalmologie, a le plaisir d’annoncer les nominations de Marcin Ernst, MD, MBA, au poste de vice-président pour l’Europe, et de Tim Neathery au poste de directeur des ressour…
Riassunto: Ora rafforza la dirigenza globale con nomine chiave in Europa e in People Services
BOSTON–(BUSINESS WIRE)–Ora, la principale azienda di ricerca clinica su contratto (CRO) nel settore oftalmico a livello globale, è lieta di annunciare le nomine di Marcin Ernst, MD, MBA e di Tim Neathery al ruolo, rispettivamente, di Vicepresidente p…
Ora verstevigt haar wereldleiderschap dankzij belangrijke benoemingen in Europa en People Services
BOSTON–(BUSINESS WIRE)–Ora, de toonaangevende internationale CRO (contract research organization) actief in oftalmologie, kondigt met genoegen de benoemingen aan van Marcin Ernst, MD, MBA, tot vicevoorzitter voor Europa, en van Tim Neathery tot Chief…
Resumen: Ora refuerza su liderazgo internacional con nombramientos clave en Europa y servicios a las personas
BOSTON–(BUSINESS WIRE)–Ora, la organización de investigación por contrato (CRO) oftálmica líder en el mundo, se complace en anunciar los nombramientos de Marcin Ernst, doctor en Medicina y máster en Administración de Empresas, como vicepresidente de …
National Vision Holdings, Inc. Announces Third Quarter 2024 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its third quarter 2024 financial results before the market opens on Wednesday, November 6, 2024 and will host a conference call …
STAAR Surgical to Report Third Quarter Results on October 30, 2024
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that it wil…
Foster Grant Unveils a Wickedly Stylish Collection of Sunglasses Ahead of Wicked Movie Release
SMITHFIELD, R.I.–(BUSINESS WIRE)–Foster Grant, one of the world’s leading over the counter eyewear brands, is thrilled to announce the release of its limited-edition Wicked x Foster Grant sunglasses collection. The custom eyewear is inspired by Unive…
Foster Grant Unveils a Wickedly Stylish Collection of Sunglasses Ahead of Wicked Movie Release
SMITHFIELD, R.I.–(BUSINESS WIRE)–Foster Grant, one of the world’s leading over the counter eyewear brands, is thrilled to announce the release of its limited-edition Wicked x Foster Grant sunglasses collection. The custom eyewear is inspired by Unive…
Foster Grant Unveils a Wickedly Stylish Collection of Sunglasses Ahead of Wicked Movie Release
SMITHFIELD, R.I.–(BUSINESS WIRE)–Foster Grant, one of the world’s leading over the counter eyewear brands, is thrilled to announce the release of its limited-edition Wicked x Foster Grant sunglasses collection. The custom eyewear is inspired by Unive…
Foster Grant Unveils a Wickedly Stylish Collection of Sunglasses Ahead of Wicked Movie Release
SMITHFIELD, R.I.–(BUSINESS WIRE)–Foster Grant, one of the world’s leading over the counter eyewear brands, is thrilled to announce the release of its limited-edition Wicked x Foster Grant sunglasses collection. The custom eyewear is inspired by Unive…
Foster Grant Unveils a Wickedly Stylish Collection of Sunglasses Ahead of Wicked Movie Release
SMITHFIELD, R.I.–(BUSINESS WIRE)–Foster Grant, one of the world’s leading over the counter eyewear brands, is thrilled to announce the release of its limited-edition Wicked x Foster Grant sunglasses collection. The custom eyewear is inspired by Unive…
Science Corp’s PRIMA Implant Restores Vision in Preliminary Clinical Trial Results
ALAMEDA, Calif.–(BUSINESS WIRE)–SCIENCE CORP’S PRIMA IMPLANT RESTORES VISION IN PRELIMINARY CLINICAL TRIAL RESULTS.
Ora Strengthens Global Leadership with Key Appointments in Europe and People Services
BOSTON–(BUSINESS WIRE)– #clinicalresearch–CRO Ora announces appointments of Dr Marcin Ernst, Vice President of Europe, and Tim Neathery, Chief People Officer, strengthening global leadership.
Genentech’s Vabysmo Improved Vision in Underrepresented Populations With Diabetic Macular Edema (DME) in a First-Of-Its-Kind Study
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline one-year results from the open-label, single-arm Phase IV ELEVATUM study evaluating Vabysmo® (faricimab-…
Riassunto: Nordic Group B.V., attraverso la sua controllata Nordic Pharma, Inc. (Stati Uniti), continua la sua presentazione di LACRIFILL ® Canalicular Gel, una nuova terapia per la sindrome dell'occhio secco, durante il congresso 2024…
BERWYN, Pa.–(BUSINESS WIRE)– Nordic Group B.V., attraverso la sua controllata Nordic Pharma, Inc. (Stati Uniti), continua la sua presentazione di LACRIFILL ® Canalicular Gel, una nuova terapia per la sindrome dell’occhio secco, durante il congresso …
Samenvatting: Via haar dochteronderneming Nordic Pharma, Inc. (U.S.) zet Nordic Group B.V. haar introductie van LACRIFILL® Canalicular Gel, een nieuwe therapie voor droge ogen, verder tijdens de AAO (American Academy of Ophthalmology) 2024
BERWYN, Pa.–(BUSINESS WIRE)–Nordic Pharma, Inc., een dochteronderneming van Nordic Group B.V., lanceerde in april LACRIFILL Canalicular Gel, een nieuwe therapie ter behandeling van droge ogen in de Verenigde Staten en zal haar introductie bij toonaan…
Resumen: Nordic Group B.V. A través de su filial Nordic Pharma, Inc. (EE.UU.), continúa su introducción del gel canalicular LACRIFILL®, una terapia novedosa para el ojo seco, durante la American Academy of Ophthalmology (AAO) 2024
BERWYN, Pensilvania–(BUSINESS WIRE)–Nordic Pharma, Inc, filial de Nordic Group B.V., lanzó en abril en EE.UU. el gel canalicular LACRIFILL, una novedosa terapia para el ojo seco, y continuará su presentación a los principales oftalmólogos durante la …
Nordic Group B.V. präsentiert über ihre Tochtergesellschaft Nordic Pharma, Inc. (U.S.) im Rahmen der American Academy of Ophthalmology (AAO) 2024 die Einführung von LACRIFILL® Canalicular Gel, einer neuartigen Therapie für trockene Augen, fort
BERWYN, Pa.–(BUSINESS WIRE)–Nordic Pharma, Inc., eine Tochtergesellschaft der Nordic Group B.V., brachte im April LACRIFILL Canalicular Gel, eine neuartige Therapie für trockene Augen, in den USA auf den Markt und wird die Einführung bei führenden Au…